Clinical Trials Logo

Clinical Trial Summary

The efficacy of TNF alfa inhibitors in the treatment of psoriasis has been documented in many studies.

Their effect on dendritic cells has been scarcely studied. TNF- α has a central role in dendritic cell biology, both for their maturity and mobilization of peripheral tissues to secondary lymphoid organs.

The primary objectives of this study are:

- To document absolute number, density of immune infiltrate and dendritic cells and inflammatory cytokines expression pattern (particularly IFN α and IL-32) in psoriasic lesions vs normal skin of the same patient

- To describe changes in such cell numbers and expression patterns upon 16 weeks treatment with TNF alfa inhibitors.


Clinical Trial Description

n/a


Study Design

Endpoint Classification: Pharmacodynamics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science


Related Conditions & MeSH terms


NCT number NCT01237262
Study type Interventional
Source University of Padova
Contact STEFANO PIASERICO, MD
Phone 0498212901
Email andrea.peserico@unipd.it
Status Not yet recruiting
Phase Phase 4
Start date November 2010